pubmed-article:8985051 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0228174 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0027540 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C1609982 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0024487 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0260061 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
pubmed-article:8985051 | lifeskim:mentions | umls-concept:C0205421 | lld:lifeskim |
pubmed-article:8985051 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:8985051 | pubmed:dateCreated | 1997-1-23 | lld:pubmed |
pubmed-article:8985051 | pubmed:abstractText | Delayed cerebral necrosis (DN) is a significant risk for brain tumor patients treated with high-dose irradiation. Although differentiating DN from tumor progression is an important clinical question, the distinction cannot be made reliably by conventional imaging techniques. We undertook a pilot study to assess the ability of proton magnetic resonance spectroscopy (1H MRS) to differentiate prospectively between DN or recurrent/residual tumor in a series of children treated for primary brain tumors with high-dose irradiation. | lld:pubmed |
pubmed-article:8985051 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8985051 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8985051 | pubmed:language | eng | lld:pubmed |
pubmed-article:8985051 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8985051 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8985051 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8985051 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8985051 | pubmed:issn | 0360-3016 | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:JenkinsJ... | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:SanfordR ARA | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:KingsleyP BPB | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:TaylorJ SJS | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:FOXJ PJP | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:ChenGG | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:HeidemanR LRL | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:LangstonJ WJW | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:HsuD WDW | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:OchsJ JJJ | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:FoxI SIS | lld:pubmed |
pubmed-article:8985051 | pubmed:author | pubmed-author:ReddickW EWE | lld:pubmed |
pubmed-article:8985051 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8985051 | pubmed:day | 1 | lld:pubmed |
pubmed-article:8985051 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:8985051 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8985051 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8985051 | pubmed:pagination | 1251-61 | lld:pubmed |
pubmed-article:8985051 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:meshHeading | pubmed-meshheading:8985051-... | lld:pubmed |
pubmed-article:8985051 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8985051 | pubmed:articleTitle | Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. | lld:pubmed |
pubmed-article:8985051 | pubmed:affiliation | Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. | lld:pubmed |
pubmed-article:8985051 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8985051 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8985051 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8985051 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8985051 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8985051 | lld:pubmed |